BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Breaking News: FDA Unbans 14 Peptides for Legal US Compounding : r PeterAttia The FDA just put BPC 157 on the calendar. July 2324 advisory panel votes on whether to restore legal compounding access for BPC 157, TB 500, and 5 more restricted peptides. This is the FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026 )